thrombin receptor peptide sfllrnp has been researched along with Atrial Fibrillation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bisping, E; Cvirn, G; Gallistl, S; Gaugler, J; Haidl, H; Jasser-Nitsche, H; Pohl, S; Schlagenhauf, A; Schwinger, W | 1 |
Ivankova, J; Kovar, F; Mokan, M; Nehaj, F; Sokol, J; Stasko, J | 1 |
1 trial(s) available for thrombin receptor peptide sfllrnp and Atrial Fibrillation
Article | Year |
---|---|
First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Aggregation; Platelet Function Tests; Pyrazoles; Pyridones; Rivaroxaban; Time Factors | 2018 |
1 other study(ies) available for thrombin receptor peptide sfllrnp and Atrial Fibrillation
Article | Year |
---|---|
Impact of electric cardioversion on platelet activation.
Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Atrial Fibrillation; Blood Coagulation; Collagen; Electric Countershock; Female; Humans; Male; Middle Aged; Peptide Fragments; Platelet Activation; Platelet Aggregation; Platelet Factor 4; Platelet Function Tests; Ristocetin; Treatment Outcome | 2021 |